<乌鸦传媒>More Evidence for Ligelizumab in Chronic Hives Anti-IgE drug showed improved activity in omalizumab-treated patients with inadequate symptom control Nov 17, 2020
<乌鸦传媒>IL-8 Antibody Active in Tumors After PD-1/L1 Blockade Clinical benefit in more than a third of patients with anti-IL-8/nivolumab combo Nov 13, 2020
<乌鸦传媒>PD-1 Inhibitor Active in Progressive Basal Cell Cancer Response rate of 20-30% with cemiplimab after post-hedgehog inhibitor progression or intolerance Nov 11, 2020
<乌鸦传媒>Watch for Suicidality in Men on Propecia Analysis found high number of psychological-related reports Nov 11, 2020
<乌鸦传媒>TYK2 Inhibition Promising in Psoriatic Arthritis Phase II study found significant benefits for two doses of novel agent Nov 10, 2020
<乌鸦传媒>Gut Bacteria for Psoriasis; Long-Term Hair Growth; COVID and STDs Selected presentations from the European Academy of Dermatology and Venereology virtual conference Nov 05, 2020
<乌鸦传媒>Nonsteroidal Topical, Nanodrug Active in Psoriasis Selected presentations from the European Academy of Dermatology and Venereology meeting Nov 04, 2020
<乌鸦传媒>Atopic Dermatitis: New Topical Agent, Durable Results With Orals Selected abstracts from the European Academy of Dermatology and Venereology Virtual Conference Nov 02, 2020
<乌鸦传媒>First-Ever Positive Phase III Trial in Epidermolysis Bullosa Faster wound healing with oleogel-S10, particularly in most common form of EB Nov 01, 2020
<乌鸦传媒>Add Skin Conditions to COVID-19 Long-Hauler Effects Persistence beyond 60 days in some cases, especially with pernio/chilblains Oct 30, 2020
<乌鸦传媒>Melanoma Survival Benefit Sustained at 5 Years With Adjuvant Combo Dabrafenib plus trametinib cut relapse risk in half Sep 02, 2020
<乌鸦传媒>Demographics Make a Difference in Common Skin Cancers Study looks at epidemiology of basal versus squamous cell carcinomas Aug 26, 2020
<乌鸦传媒>Calcineurin Blockers for Eczema: No Cancer Signal in Big Study "Clinicians can use this evidence to counsel and reassure patients" Aug 12, 2020
<乌鸦传媒>New Insights Into Radiation-Induced Hair Loss Total dose and fraction size matter, minoxidil may spur regrowth Aug 05, 2020
<乌鸦传媒>Skin Rashes a Clue to COVID-19 Vascular Disease Certain skin manifestations tied to coagulopathy in the sickest patients Aug 05, 2020
<乌鸦传媒>Triplet OK'd as First-Line Therapy in Melanoma Immunotherapy plus targeted combo nets FDA approval in BRAF-mutant population Jul 31, 2020
<乌鸦传媒>DPP-4 Inhibitors Tied to Blistering Skin Condition Increased risk for bullous pemphigoid modified by patient age, race Jul 22, 2020
<乌鸦传媒>Targeting IL-23 Relieves Multiple Symptoms in PsA Both enthesitis and dactylitis improved with guselkumab treatment in psoriatic arthritis Jul 21, 2020
<乌鸦传媒>COVID-19 May Manifest in the Mouth in Some Patients Pay attention to those with a rash, small case series from Spain advises Jul 15, 2020
<乌鸦传媒>Psoriasis Cream Succeeds in Early Trial PDE-4 inhibitor helped clear plaque psoriasis in 6 weeks Jul 15, 2020
<乌鸦传媒>Audio-Only Telemedicine: Docs Say Payment Falls Short Clinicians wonder why the technology used, not a virtual visit's content or complexity, dictates reimbursement Jul 13, 2020
<乌鸦传媒>Sobering Data on Risks of Short-Term Oral Corticosteroids Short steroid bursts linked to serious adverse events within a month Jul 06, 2020
<乌鸦传媒>Minimal Link Between Eczema and Most Cancers Study finds severe eczema tied to small risk for lymphoma Jun 30, 2020
<乌鸦传媒>Cancer Immunotherapy Tied to Severe COVID-19 Outcomes Nearly threefold increased risk of hospitalization, severe respiratory illness Jun 25, 2020
<乌鸦传媒>Psoriatic Arthritis: Outcomes Similar for Cosentyx and Humira Primary endpoint of superiority for secukinumab over adalimumab not met in a phase IIIb trial Jun 08, 2020
<乌鸦传媒>Once-Daily Abrocitinib Succeeds for Atopic Dermatitis Oral treatment acts as JAK inhibitor Jun 05, 2020
<乌鸦传媒>EULAR 2020: What to Expect Cancelled due to pandemic but extensive menu of virtual learning planned Jun 02, 2020
<乌鸦传媒>Biologics Don't Increase Melanoma Risk... Probably Meta-analysis offers some reassurance, but leaves room for doubt May 20, 2020
<乌鸦传媒>Face-Aging Selfies Help Modify Risky Skin Behaviors for Teens Trial looked at effects of a free "UV-selfie" app May 07, 2020
<乌鸦传媒>6-Week Keytruda Safe, Effective in Melanoma Schedule gets FDA approval for all adult indications Apr 30, 2020
<乌鸦传媒>Hidradenitis Suppurativa Closely Linked with Childhood Weight Prevalence of the painful skin condition will likely increase with rising childhood obesity rates, Danish researchers say Apr 30, 2020
<乌鸦传媒>Derm Residents Protest Board's In-Person Certification Exam Must travel to Florida in July for required test Apr 28, 2020
<乌鸦传媒>Triplet Succeeds in BRAF-Mutant Melanoma Immunotherapy plus BRAF/MEK inhibition boosts PFS over targeted agents alone Apr 27, 2020
<乌鸦传媒>Guselkumab a Hit in Phase III for PsA Primary endpoints met in two large trials in psoriatic arthritis for IL-23 inhibitor Apr 10, 2020
<乌鸦传媒>Psoriasis IL-23 Biologic Maintains Efficacy in 2-Year Trial Phase III trial looked at risankizumab (Skyrizi) Apr 08, 2020
<乌鸦传媒>How Prevalent Is Checkpoint Inhibitor Thyroid Dysfunction, Really? Real-world data offer word of caution for oncologists Apr 01, 2020
<乌鸦传媒>DOAC Works in Cancer-Related VTE, No Tradeoff in Bleeds Apixaban monotherapy matches dalteparin in non-inferiority trial Mar 29, 2020
<乌鸦传媒>Phase II Success for Oral CKD-Related Pruritus Agent Novel drug activates kappa opioid receptors Mar 27, 2020
<乌鸦传媒>No Major Pregnancy Problems Seen With Antifungal Derm Drug But caution urged nonetheless Mar 04, 2020
